We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 137 results
  1. Cerebellar-Induced Aphasia After Stroke: Evidence for the “Linguistic Cerebellum”

    The cerebellum is traditionally known to subserve motor functions. However, for several decades, the concept of the “cerebellar cognitive affective...

    Djaina Satoer, Peter J. Koudstaal, ... Ruben S. van der Giessen in The Cerebellum
    Article Open access 20 January 2024
  2. Cortical microstructure in primary progressive aphasia: a multicenter study

    Background

    Cortical mean diffusivity is a novel imaging metric sensitive to early changes in neurodegenerative syndromes. Higher cortical mean...

    Ignacio Illán-Gala, Victor Montal, ... Juan Fortea in Alzheimer's Research & Therapy
    Article Open access 09 February 2022
  3. Diagnostic accuracy of research criteria for prodromal frontotemporal dementia

    Background

    The Genetic Frontotemporal Initiative Staging Group has proposed clinical criteria for the diagnosis of prodromal frontotemporal dementia...

    Alberto Benussi, Enrico Premi, ... Sónia Afonso in Alzheimer's Research & Therapy
    Article Open access 12 January 2024
  4. Mild behavioral impairment in early Alzheimer’s disease and its association with APOE and BDNF risk genetic polymorphisms

    Background

    Mild behavioral impairment (MBI) has been commonly reported in early Alzheimer’s disease (AD) but rarely using biomarker-defined samples....

    Veronika Matuskova, Katerina Veverova, ... Martin Vyhnalek in Alzheimer's Research & Therapy
    Article Open access 26 January 2024
  5. Retinal microvasculature dysfunction is associated with Alzheimer’s disease and mild cognitive impairment

    Background

    The retina and brain share many neuronal and vasculature characteristics. We investigated the retinal microvasculature in Alzheimer’s...

    Jacqueline Chua, Qinglan Hu, ... Leopold Schmetterer in Alzheimer's Research & Therapy
    Article Open access 04 December 2020
  6. Selecting and Handling Behavioral Measures for Lesion-Symptom Map**

    The success of a lesion-symptom map**Lesion symptom map** (LSM) (LSM) study in answering a specific research question critically depends on how...
    Peter E. Turkeltaub, Andrew T. DeMarco, Maryam Ghaleh in Lesion-to-Symptom Map**
    Protocol 2022
  7. Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts

    Background

    Cerebrospinal fluid (CSF) p-tau235 is a novel biomarker highly specific of Alzheimer’s disease (AD). However, CSF p-tau235 has only been...

    Juan Lantero-Rodriguez, Agathe Vrillon, ... Kaj Blennow in Alzheimer's Research & Therapy
    Article Open access 10 March 2023
  8. Let Us Talk Money: Subjectively Reported Financial Performance of People Living with Neurodegenerative Diseases—A Systematic Review

    Neurodegenerative diseases (NDDs) form a heterogeneous, widespread group of disorders, generally characterized by progressive cognitive decline and...

    Akke-Marij D. Ariesen, Roosa E. Tuomainen, ... Janneke Koerts in Neuropsychology Review
    Article Open access 18 August 2023
  9. Inference comprehension from reading in individuals with mild cognitive impairment

    Inference comprehension is a complex ability that recruits distinct cognitive domains, such as language, memory, attention, and executive functions....

    Marcela Lima Silagi, Vivian Urbanejo Romero, ... Leticia Lessa Mansur in Acta Neurologica Belgica
    Article 22 January 2020
  10. A systematic survey of advances in retinal imaging modalities for Alzheimer’s disease diagnosis

    Recent advances in retinal imaging pathophysiology have shown a new function for biomarkers in Alzheimer’s disease diagnosis and prognosis. The...

    Richa Vij, Sakshi Arora in Metabolic Brain Disease
    Article 15 March 2022
  11. Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

    Background

    Neuroinflammation is emerging as an important pathological process in frontotemporal dementia (FTD), but biomarkers are lacking. We aimed...

    Emma L. van der Ende, Carolin Heller, ... Miren Zulaica in Journal of Neuroinflammation
    Article Open access 05 September 2022
  12. Characteristics of behavioral symptoms in right-sided predominant semantic dementia and their impact on caregiver burden: a cross-sectional study

    Background

    This study aimed to clarify the neuropsychiatric symptoms of right-sided predominant semantic dementia (SD-R) by comparing them with those...

    Shunsuke Sato, Mamoru Hashimoto, ... Manabu Ikeda in Alzheimer's Research & Therapy
    Article Open access 09 October 2021
  13. Heterogeneity in Alzheimer’s Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials

    The clinical presentation and the pathological processes underlying Alzheimer’s disease (AD) can be very heterogeneous in severity, location, and...

    Ranjan Duara, Warren Barker in Neurotherapeutics
    Article 27 January 2022
  14. Preliminary validation of the apraxia battery for adults-second edition (ABA-2) in Greek patients with dementia

    Background

    Apraxia is considered a supportive feature in Alzheimer’s disease (AD) patients. It has been reported that patients with frontotemporal...

    Georgios Papadopoulos, Dimitrios Parissis, ... Panagiotis Ioannidis in Acta Neurologica Belgica
    Article 01 September 2021
  15. Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals

    Background

    To systematically examine the clinical utility of tau-PET and Braak-staging as prognostic markers of future cognitive decline in older...

    Davina Biel, Matthias Brendel, ... Nicolai Franzmeier in Alzheimer's Research & Therapy
    Article Open access 12 August 2021
  16. Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status

    Objective

    We assessed the performance of plasma amyloid oligomerization tendency (OAβ) as a marker for abnormal amyloid status. Additionally, we...

    Rosha Babapour Mofrad, Philip Scheltens, ... Charlotte E. Teunissen in Alzheimer's Research & Therapy
    Article Open access 26 July 2021
  17. Neurodegenerative pathologies associated with behavioral and psychological symptoms of dementia in a community-based autopsy cohort

    In addition to the memory disorders and global cognitive impairment that accompany neurodegenerative diseases, behavioral and psychological symptoms...

    Ruth S. Nelson, Erin L. Abner, ... Peter T. Nelson in Acta Neuropathologica Communications
    Article Open access 02 June 2023
  18. Measures of Subjective Memory for People with Epilepsy: A Systematic Review of Measurement Properties

    People with epilepsy frequently express concern about the burden of memory problems in their everyday lives. Self-report memory questionnaires may...

    Kate Thompson, Ada H. Y. Lo, ... David C. Reutens in Neuropsychology Review
    Article 12 January 2023
  19. Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results

    GRN mutations cause progranulin haploinsufficiency, which eventually leads to frontotemporal dementia (FTD-GRN). PR006 is an investigational gene...

    Jeffrey Sevigny, Olga Uspenskaya, ... Franz Hefti in Nature Medicine
    Article Open access 14 May 2024
  20. An MRI-based strategy for differentiation of frontotemporal dementia and Alzheimer’s disease

    Background

    The differential diagnosis of frontotemporal dementia (FTD) and Alzheimer’s disease (AD) is difficult due to the overlaps of clinical...

    Qun Yu, Yingren Mai, ... Maria Luisa Mandelli in Alzheimer's Research & Therapy
    Article Open access 12 January 2021
Did you find what you were looking for? Share feedback.